Press releases
- Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel)
- Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
- Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
- Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
Key statistics
On Friday, Rocket Pharmaceuticals Inc (9IP1:DEU) closed at 23.93, -19.99% below its 52-week high of 29.91, set on Dec 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.51 |
---|---|
High | 24.31 |
Low | 23.51 |
Bid | 23.05 |
Offer | 23.61 |
Previous close | 23.49 |
Average volume | 61.60 |
---|---|
Shares outstanding | 90.78m |
Free float | 85.86m |
P/E (TTM) | -- |
Market cap | 2.30bn USD |
EPS (TTM) | -2.87 USD |
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼